152 related articles for article (PubMed ID: 4031663)
1. Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man.
Berr F; Eckel R; Kern F
J Lipid Res; 1985 Jul; 26(7):852-9. PubMed ID: 4031663
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
Berr F; Eckel RH; Kern F
J Lipid Res; 1986 Jun; 27(6):645-51. PubMed ID: 3746133
[TBL] [Abstract][Full Text] [Related]
3. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
Berr F; Kern F
J Lipid Res; 1984 Aug; 25(8):805-12. PubMed ID: 6491526
[TBL] [Abstract][Full Text] [Related]
4. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans.
Berr F
J Lipid Res; 1992 Jun; 33(6):915-30. PubMed ID: 1512515
[TBL] [Abstract][Full Text] [Related]
5. Effects of estrogen/progestin agents on plasma retinoids and chylomicron remnant metabolism.
Gleeson JM; Dukes CS; Elstad NL; Chan IF; Wilson DE
Contraception; 1987 Jan; 35(1):69-78. PubMed ID: 3568661
[TBL] [Abstract][Full Text] [Related]
6. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers.
Pimstone SN; Clee SM; Gagné SE; Miao L; Zhang H; Stein EA; Hayden MR
J Lipid Res; 1996 Aug; 37(8):1675-84. PubMed ID: 8864951
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
Cortner JA; Coates PM; Le NA; Cryer DR; Ragni MC; Faulkner A; Langer T
J Lipid Res; 1987 Feb; 28(2):195-206. PubMed ID: 3572247
[TBL] [Abstract][Full Text] [Related]
8. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.
Karpe F; Olivecrona T; Hamsten A; Hultin M
J Lipid Res; 1997 May; 38(5):949-61. PubMed ID: 9186912
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester.
van Bennekum AM; Kako Y; Weinstock PH; Harrison EH; Deckelbaum RJ; Goldberg IJ; Blaner WS
J Lipid Res; 1999 Mar; 40(3):565-74. PubMed ID: 10064745
[TBL] [Abstract][Full Text] [Related]
10. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.
Brenninkmeijer BJ; Stuyt PM; Demacker PN; Stalenhoef AF; van 't Laar A
J Lipid Res; 1987 Apr; 28(4):361-70. PubMed ID: 3585171
[TBL] [Abstract][Full Text] [Related]
11. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
Smith D; Watts GF; Dane-Stewart C; Mamo JC
Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins.
Lemieux S; Fontani R; Uffelman KD; Lewis GF; Steiner G
J Lipid Res; 1998 Oct; 39(10):1964-71. PubMed ID: 9788242
[TBL] [Abstract][Full Text] [Related]
13. Effect of fasting on two postheparin plasma triglyceride lipases and triglyceride removal in obese subjects.
Huttunen JK; Ehnholm C; Nikkilä EA; Ohta M
Eur J Clin Invest; 1975 Nov; 5(6):435-45. PubMed ID: 1201762
[TBL] [Abstract][Full Text] [Related]
14. Chylomicron beta-carotene and retinyl palmitate responses are dramatically diminished when men ingest beta-carotene with medium-chain rather than long-chain triglycerides.
Borel P; Tyssandier V; Mekki N; Grolier P; Rochette Y; Alexandre-Gouabau MC; Lairon D; Azaïs-Braesco V
J Nutr; 1998 Aug; 128(8):1361-7. PubMed ID: 9687557
[TBL] [Abstract][Full Text] [Related]
15. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
Groot PH; van Stiphout WA; Krauss XH; Jansen H; van Tol A; van Ramshorst E; Chin-On S; Hofman A; Cresswell SR; Havekes L
Arterioscler Thromb; 1991; 11(3):653-62. PubMed ID: 2029503
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
Cabezas MC; de Bruin TW; Kock LA; Kortlandt W; Van Linde-Sibenius Trip M; Jansen H; Erkelens DW
Metabolism; 1993 Apr; 42(4):497-503. PubMed ID: 8487674
[TBL] [Abstract][Full Text] [Related]
17. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
Karpe F; Bell M; Björkegren J; Hamsten A
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):199-207. PubMed ID: 7749826
[TBL] [Abstract][Full Text] [Related]
18. Effect of copper deficiency on the lymphatic absorption of cholesterol, plasma chylomicron clearance, and postheparin lipase activities.
Koo SI; Lee CC; Norvell JE
Proc Soc Exp Biol Med; 1988 Sep; 188(4):410-9. PubMed ID: 3420106
[TBL] [Abstract][Full Text] [Related]
19. Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans.
Karpe F; Humphreys SM; Samra JS; Summers LK; Frayn KN
J Lipid Res; 1997 Nov; 38(11):2335-43. PubMed ID: 9392431
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
Brunzell JD; Hazzard WR; Porte D; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
